Outcome of docetaxel in treatment of metastatic hormone-sensitive prostate cancer and correlation with hemoglobin, albumin, lymphocyte and platelets score.
Saved in:
| Title: | Outcome of docetaxel in treatment of metastatic hormone-sensitive prostate cancer and correlation with hemoglobin, albumin, lymphocyte and platelets score. |
|---|---|
| Authors: | Taha HF; Medical Oncology Department, Zagazig University, Zagazig, Egypt., Elsayed DH; Medical Oncology Department, Zagazig University, Zagazig, Egypt., Salem R; Clinical Oncology and nuclear medicine department, Zagazig University, Zagazig, Egypt., Mandour D; Clinical Oncology and nuclear medicine department, Zagazig University, Zagazig, Egypt., Bayomy M; Clinical Oncology and nuclear medicine department, Zagazig University, Zagazig, Egypt., Rashed H; Pathology Department, Zagazig University, Zagazig, Egypt., Kamel M; Urology Department, Zagazig University, Zagazig, Egypt., Elderey M; Urology Department, Zagazig University, Zagazig, Egypt., Elfarargy OM; Medical Oncology Department, Zagazig University, Zagazig, Egypt. |
| Source: | Contemporary oncology (Poznan, Poland) [Contemp Oncol (Pozn)] 2022; Vol. 26 (3), pp. 196-203. Date of Electronic Publication: 2022 Oct 24. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Termedia Country of Publication: Poland NLM ID: 101233223 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1428-2526 (Print) Linking ISSN: 14282526 NLM ISO Abbreviation: Contemp Oncol (Pozn) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
